Genmab A/S (GNMSF)
281.75
0.00 (0.00%)
USD |
OTCM |
Apr 17, 16:00
Genmab Market Cap : 17.32B for April 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 15.01B |
| Zealand Pharma A/S | 3.625B |
| Bavarian Nordic A/S | 2.430B |
| ALK-Abello A/S | 6.946B |
Market Cap Related Metrics
| PE Ratio | 18.26 |
| PS Ratio | 4.824 |
| Price to Book Value | 2.963 |
| Price to Free Cash Flow | 15.40 |
| Price | 281.75 |
| Earnings Yield | 5.48% |
| Operating PE Ratio | 14.36 |
| Normalized PE Ratio | 16.23 |